BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/16/2024 6:17:54 AM | Browse: 82 | Download: 259
 |
Received |
|
2024-03-12 15:24 |
|
Peer-Review Started |
|
2024-03-12 15:24 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-29 08:13 |
|
Revised |
|
2024-05-11 06:00 |
|
Second Decision |
|
2024-06-03 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-03 07:04 |
|
Articles in Press |
|
2024-06-03 07:04 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-06-24 19:04 |
|
Typeset the Manuscript |
|
2024-07-09 07:41 |
|
Publish the Manuscript Online |
|
2024-07-16 06:17 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Impact of hyperthermic intraperitoneal chemotherapy on gastric cancer survival: Peritoneal metastasis and cytology perspectives
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Asada Methasate, Thammawat Parakonthun, Thita Intralawan, Chawisa Nampoolsuksan and Jirawat Swangsri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Thammawat Parakonthun, MD, Associate Professor, Minimally Invasive Surgery Unit, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wang Lang Road, Bangkok 10700, Thailand. thammawat.paa@mahidol.edu |
| Key Words |
Cytoreductive surgery; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Peritoneal metastasis; Positive cytology |
| Core Tip |
This investigation evaluated the survival outcomes of 84 advanced gastric cancer patients from 2013 to 2020. Among them, the hyperthermic intraperitoneal chemotherapy (HIPEC) cohort, characterized by peritoneal nodules, underwent longer surgeries and experienced greater blood loss, yet the rate of complications did not significantly differ among groups. The HIPEC group’s median survival was 20.00 ± 4.89 months, with 1-year, 2-year, and 3-year survival rates of 73.90%, 28.70%, and 9.60%, respectively. These rates were akin to those of the cytology-positive group. While HIPEC appears to offer a survival benefit, particularly in the short term, the incidence of peritoneal recurrence remains notably high. |
| Publish Date |
2024-07-16 06:17 |
| Citation |
<p>Methasate A, Parakonthun T, Intralawan T, Nampoolsuksan C, Swangsri J. Impact of hyperthermic intraperitoneal chemotherapy on gastric cancer survival: Peritoneal metastasis and cytology perspectives. <i>World J Clin Oncol</i> 2024; 15(7): 840-847</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i7/840.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i7.840 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
